slides · global inventory
Chart Selection Guide
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,343
Current window 241-270
Pages 279
Rows per page 30
Tool
241-270 of 8,343
23
The slide uses two distinct chart types: a scatter plot for binding affinity and a dose-response curve for functional inhibition.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 2 hits
18
The slide uses a structural model of the protein complex and two dose-response curves to demonstrate efficacy and selectivity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
18
The slide highlights the correlation between overall net sales and the specific growth in alcohol dependence utilization, noting a COVID-19 impact in 2020.Alkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Beat · Product2 hits
03
The slide includes a footnote explaining F/X adjusted metrics.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials2 hits
21
Includes IC50 value and IFN-y fold increase data from patient samples.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
23
Includes both longitudinal efficacy data (line chart) and pharmacokinetic data (bar charts) comparing plasma vs liver concentrations.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution2 hits
25
The slide uses a three-column layout to present clinical data for three distinct drug combinations.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 2 hits
11
The slide uses a dual-pillar structure to present sustainability goals and quantitative targets for 2025, 2030, and 2050.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)2 hits
09
Broadridge Financial Solutions | Results Presentation Deck | 31 slidesBroadridge Financial Solutions | Results Presentation Deck | 31 slides · Broadridge
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction2 hits
15
Broadridge Financial Solutions | Results Presentation Deck | 37 slidesBroadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
17
The slide uses two different chart types to show total growth and segment-specific growth.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
18
The slide uses a donut chart to represent the platform scale and a bar chart to show growth over time.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
06
The slide presents two bar charts side-by-side to illustrate positive business trends.Cyxtera | Results Presentation Deck | 27 slides · Cyxtera
Conference presentation Investor relations 2 hits
12
Cyxtera | Results Presentation Deck | 27 slidesCyxtera | Results Presentation Deck | 27 slides · Cyxtera
Conference presentation Investor relations 2 hits
34
The slide compares tumor growth inhibition across two cancer types using different dosages of EXS617.Exscientia | Investor Presentation Deck | 37 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
35
The slide uses a multi-panel line chart layout to compare drug efficacy and toxicity across different time points and cell types.Exscientia | Investor Presentation Deck | 37 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
36
The slide uses small multiples to show dose-response curves for individual patient samples, then aggregates them into two groups (I and II) to demonstrate differential sensitivity.Exscientia | Investor Presentation Deck | 37 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle2 hits
43
Includes comparison between FFB and FFI for leverage and risk-based capital ratios.First Foundation | Investor Presentation Deck | 48 slides · First Foundation
Conference presentation Investor relations 2 hits
24
Includes detailed footnotes regarding acquisitions and methodology.Houlihan Lokey | Investment Banking Pitch Book | 42 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Financials2 hits
25
Includes a detailed disclaimer regarding historical financial data and adjustments.Houlihan Lokey | Investment Banking Pitch Book | 42 slides · Houlihan Lokey
Consulting deck Investment bank Beat · Financials2 hits
52
The slide highlights the growth in management fees alongside a decline in performance fees due to market conditions.Jefferies Financial Group | Investor Day Presentation Deck | 76 slides · Jefferies
Conference presentation Investor relations 2 hits
12
Includes PK/PD correlation, IRAK4 levels in PBMC, and skin lesion reduction data.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
27
The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 2 hits
13
The slide uses dot plots to show IC50 values for different drugs across fusion partners and mutations, and a bar chart to show tumor regression efficacy.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test2 hits
14
The chart on the right uses a log scale for the y-axis to visualize selectivity indices.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test2 hits
24
The slide uses a combination of historical annual data and year-to-date (9/30/22) figures to demonstrate business scalability.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · Market Size2 hits
28
South Plains Financial | Investor Presentation Deck | 35 slidesSouth Plains Financial | Investor Presentation Deck | 35 slides · South Plains Financial
Pitch deck Investor relations Beat · Satisfaction2 hits
40
Includes a histogram of transaction premiums and a scatter plot of transaction size vs. premium, highlighting TRQ/Rio Tinto data points.TD Securities | Investment Banking Pitch Book | 42 slides · TD Securities
Deck Investment bank 2 hits
06
Includes a waterfall-style revenue comparison and a bar chart for YouTube channel growth.Trifork | Investor Conference Presentation Deck | 31 slides · Trifork
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
13
Includes revenue growth comparisons between Q1 2021 and Q1 2022 for each vertical.Trifork | Investor Conference Presentation Deck | 31 slides · Trifork
Conference presentation Investor relations Beat · Solution2 hits